Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.65 USD | +0.15% |
|
+11.95% | -47.84% |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- The company's Refinitiv ESG score, based on a relative ranking of the company within its sector, comes out particularly poor.
Weaknesses
- The company's profitability before interest, taxes, depreciation and amortization characterizes fragile margins.
- The company has insufficient levels of profitability.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The average consensus view of analysts covering the stock has deteriorated over the past four months.
- Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-47.84% | 412M | C- | ||
+75.69% | 12.57B | - | B- | |
-28.45% | 6.98B | C+ | ||
+7.45% | 6.69B | C- | ||
+8.73% | 5.18B | D+ | ||
-19.73% | 4.63B | B | ||
+17.40% | 4.18B | - | ||
-21.68% | 3.81B | B- | ||
-25.83% | 2.8B | C | ||
-1.24% | 2B | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- TMCI Stock
- Ratings Treace Medical Concepts, Inc.